Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis
First patient dosed with CK0803 Treg cells for treatment of amyotrophic lateral sclerosis (ALS). Ongoing Phase 1/1b study evaluating safety
Read More